Science
FDA Approves Durata Drug to Treat Acute Skin Infections
The Food and Drug Administration announced Friday announced that it has approved Durata Therapeutics' drug Dalvance (dalbavancin) that treats skin infections.
Latest Research Articles
Junk Food Linked to Preterm Birth Risk
Women Happier at Work than Home, Study Finds
Fruit Flies Analyze Information Before Making Difficult Decisions
Microbes Break Genetic Code Quite Often, Study Finds [Video]
Melting Ice Sheets Could Trigger Unexpected Volcanic Activity
Congress Hears About the Hunt For Alien Life
Healthy Placentas are Home to Several Good Germs: Study
Researchers Create a Graphene-Like Material
Top Ten New Species 2014 List Includes Carnivore That looks Like a Teddy Bear
Comb Jellies Show there is More than One Way to Make a Brain
Double Mastectomy Not Recommended for Most Breast Cancer Patients
New Species of Praying Mantis that Hunts Like a Tiger Found in Rwanda Forest
MOST POPULAR
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
How Earthquakes 'Ignite': Hidden Mechanism Discovered in New Study
-
Volcanic Eruptions Linked to Neolithic Sun Stone Sacrifices in Denmark
-
Homo Erectus Mastered Desert Survival 1.2 Million Years Ago
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
